Literature DB >> 24482508

Trypanosoma cruzi Clone Dm28c Draft Genome Sequence.

Edmundo Carlos Grisard1, Santuza Maria Ribeiro Teixeira, Luiz Gonzaga Paula de Almeida, Patricia Hermes Stoco, Alexandra Lehmkuhl Gerber, Carlos Talavera-López, Oberdan Cunha Lima, Björn Andersson, Ana Tereza R de Vasconcelos.   

Abstract

Trypanosoma cruzi affects millions of people worldwide. Clinical variability of Chagas disease can be due to the genetic variability of this parasite, requiring further genome studies. Here we report the genome sequence of the T. cruzi Dm28c clone (TcI), a strain related to the sylvatic cycle of the parasite.

Entities:  

Year:  2014        PMID: 24482508      PMCID: PMC3907723          DOI: 10.1128/genomeA.01114-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Trypanosoma cruzi is a protozoan parasite that causes Chagas disease, an illness that affects 8 to 10 million people in Latin America. The genetic variability found in the parasite population allows classification of strains into six major groups (TcI through TcVI) (1). In 2005, the T. cruzi CL Brener clone genome was published (2), but its complete assembly was hindered by repeated sequences and the hybrid nature of this strain. Other genomes, such as the Sylvio X10/1 strain, have been published (3), allowing comparative analyses to assess the variable clinical forms of Chagas disease. Whereas CL Brener (TcVI), together with the TcII and TcV strains, is the predominant cause of Chagas disease in the Southern Cone of Latin America (1, 2), Sylvio X10/1 and Dm28c belong to TcI, a group related to the sylvatic cycle that is also associated with Chagas disease in the Brazilian Amazon, Venezuela, Colombia, and Central America (3). Here, we present the genome sequence of the T. cruzi clone Dm28c (4), which has been widely used as a model for biochemistry, cell biology, immunology, gene expression, and drug development studies. Sequencing was carried out using the 454 GS-FLX Titanium platform. Two shotgun libraries and one 3-kb paired-end (PE) library were constructed using ±5 µg of Dm28c DNA isolated from epimastigote cultures. Library construction, titration, emulsion PCR, and sequencing steps were performed according to the manufacturer’s protocol. Assembly of the Dm28c genome was carried out by processing the 454 SFF files using custom Perl scripts to generate paired-end (PE) FASTQ files. The SFF files were subsequently assembled using the Newbler software and the output was scaffolded using SSPACE 2.1.0. Gaps were improved by use of GapFiller 1.11 prior to automated annotation. Using this protocol, a total number of 5,287 contigs were generated, and 91.7% of them (4,848) were assembled into 1,378 scaffolds, totaling 30,716,540 bp. The longest contig was 89,747 bp. Automated functional annotation was performed de novo using the System for Automated Bacterial Integrated Annotation (SABIA) (5). We identified 4,144 proteins with homology to known proteins from other organisms as well as 7,254 hypothetical proteins, with a coding sequence (CDS) average length of 1,397 bp. With an estimated haploid genome size of 27 Mbp and a G+C content of 53.26%, Dm28c is more similar, as expected, to Sylvio X10/1 (98.71% nucleotide sequence identity) than to CL Brener (90.20%), as revealed by a stringent Megablast analysis of both coding and noncoding regions. Accordingly, the Bidirectional Best Hit (BBH) analysis showed that DM28c has 6,094 proteins with best hits with SylvioX-10 and 5,267 proteins with best hits with CL Brener. The assembled genome together with the functional annotation is available on http://www.labinfo.lncc.br/index.php/trypanosoma-cruzi-dm28.

Nucleotide sequence accession number.

The T. cruzi Dm28c genome sequence is available in GenBank with the accession number AYLP00000000.
  5 in total

1.  A System for Automated Bacterial (genome) Integrated Annotation--SABIA.

Authors:  Luiz G P Almeida; Roger Paixão; Rangel C Souza; Gisele C da Costa; Frank J A Barrientos; M Trindade dos Santos; Darcy F de Almeida; Ana Tereza R Vasconcelos
Journal:  Bioinformatics       Date:  2004-04-15       Impact factor: 6.937

2.  Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media.

Authors:  V T Contreras; T C Araujo-Jorge; M C Bonaldo; N Thomaz; H S Barbosa; M de N Meirelles; S Goldenberg
Journal:  Mem Inst Oswaldo Cruz       Date:  1988 Jan-Mar       Impact factor: 2.743

Review 3.  The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications.

Authors:  Bianca Zingales; Michael A Miles; David A Campbell; Michel Tibayrenc; Andrea M Macedo; Marta M G Teixeira; Alejandro G Schijman; Martin S Llewellyn; Eliane Lages-Silva; Carlos R Machado; Sonia G Andrade; Nancy R Sturm
Journal:  Infect Genet Evol       Date:  2011-12-27       Impact factor: 3.342

4.  The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease.

Authors:  Najib M El-Sayed; Peter J Myler; Daniella C Bartholomeu; Daniel Nilsson; Gautam Aggarwal; Anh-Nhi Tran; Elodie Ghedin; Elizabeth A Worthey; Arthur L Delcher; Gaëlle Blandin; Scott J Westenberger; Elisabet Caler; Gustavo C Cerqueira; Carole Branche; Brian Haas; Atashi Anupama; Erik Arner; Lena Aslund; Philip Attipoe; Esteban Bontempi; Frédéric Bringaud; Peter Burton; Eithon Cadag; David A Campbell; Mark Carrington; Jonathan Crabtree; Hamid Darban; Jose Franco da Silveira; Pieter de Jong; Kimberly Edwards; Paul T Englund; Gholam Fazelina; Tamara Feldblyum; Marcela Ferella; Alberto Carlos Frasch; Keith Gull; David Horn; Lihua Hou; Yiting Huang; Ellen Kindlund; Michele Klingbeil; Sindy Kluge; Hean Koo; Daniela Lacerda; Mariano J Levin; Hernan Lorenzi; Tin Louie; Carlos Renato Machado; Richard McCulloch; Alan McKenna; Yumi Mizuno; Jeremy C Mottram; Siri Nelson; Stephen Ochaya; Kazutoyo Osoegawa; Grace Pai; Marilyn Parsons; Martin Pentony; Ulf Pettersson; Mihai Pop; Jose Luis Ramirez; Joel Rinta; Laura Robertson; Steven L Salzberg; Daniel O Sanchez; Amber Seyler; Reuben Sharma; Jyoti Shetty; Anjana J Simpson; Ellen Sisk; Martti T Tammi; Rick Tarleton; Santuza Teixeira; Susan Van Aken; Christy Vogt; Pauline N Ward; Bill Wickstead; Jennifer Wortman; Owen White; Claire M Fraser; Kenneth D Stuart; Björn Andersson
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

5.  Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener.

Authors:  Oscar Franzén; Stephen Ochaya; Ellen Sherwood; Michael D Lewis; Martin S Llewellyn; Michael A Miles; Björn Andersson
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08
  5 in total
  15 in total

1.  The Hsp70/J-protein machinery of the African trypanosome, Trypanosoma brucei.

Authors:  Stephen John Bentley; Miebaka Jamabo; Aileen Boshoff
Journal:  Cell Stress Chaperones       Date:  2018-12-01       Impact factor: 3.667

2.  Cytosolic Fe-superoxide dismutase safeguards Trypanosoma cruzi from macrophage-derived superoxide radical.

Authors:  Alejandra Martínez; Carolina Prolo; Damián Estrada; Natalia Rios; María Noel Alvarez; María Dolores Piñeyro; Carlos Robello; Rafael Radi; Lucía Piacenza
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-12       Impact factor: 11.205

3.  Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.

Authors:  Sean Ekins; Jair Lage de Siqueira-Neto; Laura-Isobel McCall; Malabika Sarker; Maneesh Yadav; Elizabeth L Ponder; E Adam Kallel; Danielle Kellar; Steven Chen; Michelle Arkin; Barry A Bunin; James H McKerrow; Carolyn Talcott
Journal:  PLoS Negl Trop Dis       Date:  2015-06-26

4.  Construction of three new Gateway® expression plasmids for Trypanosoma cruzi.

Authors:  Victoria L Alonso; Carla Ritagliati; Pamela Cribb; Esteban C Serra
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-11-21       Impact factor: 2.743

5.  Transcriptomic analysis reveals metabolic switches and surface remodeling as key processes for stage transition in Trypanosoma cruzi.

Authors:  Luisa Berná; Maria Laura Chiribao; Gonzalo Greif; Matias Rodriguez; Fernando Alvarez-Valin; Carlos Robello
Journal:  PeerJ       Date:  2017-03-08       Impact factor: 2.984

6.  Expanding an expanded genome: long-read sequencing of Trypanosoma cruzi.

Authors:  Luisa Berná; Matias Rodriguez; María Laura Chiribao; Adriana Parodi-Talice; Sebastián Pita; Gastón Rijo; Fernando Alvarez-Valin; Carlos Robello
Journal:  Microb Genom       Date:  2018-04-30

7.  Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity.

Authors:  Caio H Franco; David C Warhurst; Tapan Bhattacharyya; Ho Y A Au; Hai Le; Miriam A Giardini; Bruno S Pascoalino; Ana Claudia Torrecilhas; Lavinia M D Romera; Rafael Pedro Madeira; Sergio Schenkman; Lucio H Freitas-Junior; Eric Chatelain; Michael A Miles; Carolina B Moraes
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-06-13       Impact factor: 4.077

8.  A complete Leishmania donovani reference genome identifies novel genetic variations associated with virulence.

Authors:  Patrick Lypaczewski; Johanna Hoshizaki; Wen-Wei Zhang; Laura-Isobel McCall; John Torcivia-Rodriguez; Vahan Simonyan; Amanpreet Kaur; Ken Dewar; Greg Matlashewski
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

9.  Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection.

Authors:  Yuan Li; Sheena Shah-Simpson; Kwame Okrah; A Trey Belew; Jungmin Choi; Kacey L Caradonna; Prasad Padmanabhan; David M Ndegwa; M Ramzi Temanni; Héctor Corrada Bravo; Najib M El-Sayed; Barbara A Burleigh
Journal:  PLoS Pathog       Date:  2016-04-05       Impact factor: 6.823

10.  Secretome analysis of Trypanosoma cruzi by proteomics studies.

Authors:  Jean-Yves Brossas; Julián Ernesto Nicolás Gulin; Margarita Maria Catalina Bisio; Manuel Chapelle; Carine Marinach-Patrice; Mallaury Bordessoules; George Palazon Ruiz; Jeremy Vion; Luc Paris; Jaime Altcheh; Dominique Mazier
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.